AGUSTIN LARA: Open Payments
NPI 1962697219 · VENTURA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,123 in 57 payments from 14 companies in 2025. Trend: 2023 $1,113 · 2024 $1,306 · 2025 $1,123
Food & beverage: $1,123
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $256 |
| ABBVIE INC. | 9 | $154 |
| AstraZeneca Pharmaceuticals LP | 7 | $136 |
| Lilly USA, LLC | 6 | $133 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $122 |
| PFIZER INC. | 4 | $78 |
| Amgen Inc. | 3 | $72 |
| GlaxoSmithKline, LLC. | 3 | $47 |
| Teleflex LLC | 1 | $32 |
| Eisai Inc. | 1 | $24 |
Products named: MOUNJARO, JARDIANCE, AIRSUPRA, VRAYLAR, Ozempic, Wegovy, OTEZLA, PREVNAR 20.
Industry payments across CA — which companies pay providers there.
